Biosimilar and biological medicines information
The Association of the British Pharmaceutical Industry (ABPI) and the UK Bioindustry Association (BIA) have jointly produced two materials designed to aid understanding of biosimilar and biological medicines. It includes an explanatory document and frequently asked questions. The BIA has also developed a concept paper on pharmacovigilance considerations for biologics. They can be downloaded from the ABPI and BIA websites.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20065946
Recommended from Pharmaceutical Press